Controlling Health Care Costs Paying for Prescription Drugs Around the World: Why Is the U.S. an Outlier? Issue Briefs / Oct 05, 2017
Controlling Health Care Costs The Case for Drug-Pricing Reform — The Cost of Inaction blog / May 26, 2021
Controlling Health Care Costs External Reference Pricing: The Drug-Pricing Reform America Needs? Issue Briefs / May 27, 2021
Controlling Health Care Costs How Federal Drug-Pricing Proposals Could Affect Medicaid blog / Aug 19, 2021
Controlling Health Care Costs Reducing Medicaid Prescription Drug Costs While Maintaining Beneficiary Access: MACPAC Recommendations for Accelerated-Approval Drugs blog / Aug 18, 2021
Controlling Health Care Costs Beyond “Most Favored Nation” Drug Pricing: What the U.S. Can Learn from Other Countries Blog / Apr 23, 2026
Controlling Health Care Costs International Lessons on Pricing and Financing High-Cost Medicines: Policy Options for the United States Issue Briefs / Apr 23, 2026
Controlling Health Care Costs How Drugmakers Use the Patent Process to Keep Prices High Explainer / Nov 13, 2025
Controlling Health Care Costs How Inflation Rebates Can Curb Drug Price Increases Explainer / Oct 28, 2025
Controlling Health Care Costs The 340B Drug Pricing Program: How It Works and Why It’s Controversial Explainer / Aug 06, 2025
Controlling Health Care Costs Medicare Drug Price Negotiations: All You Need to Know Explainer / May 15, 2025
Controlling Health Care Costs What Pharmacy Benefit Managers Do, and How They Contribute to Drug Spending Explainer / Mar 17, 2025
Controlling Health Care Costs How the Federal Government Could Support Innovative Medicaid Payment Arrangements for High-Cost Drugs Blog / Mar 12, 2025
Controlling Health Care Costs Drug Costs and Their Impact on Care: Insights from Medicare Patients and Providers Issue Briefs / Feb 10, 2025
Achieving Universal Coverage Hispanic/Latino Adults Lack Adequate, Affordable Health Insurance Coverage Blog / Dec 17, 2024